EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of chronic trypanosomiasis on the bioavailability of alpha -difluoromethylornithine (DFMO) after oral administration: pharmacokinetics study on DFMO plasma levels in infected and noninfected mice using a high-performance liquid chromatography assay



Effect of chronic trypanosomiasis on the bioavailability of alpha -difluoromethylornithine (DFMO) after oral administration: pharmacokinetics study on DFMO plasma levels in infected and noninfected mice using a high-performance liquid chromatography assay



Parasitology Research 83(4): 386-389



A method for detecting alpha -difluoromethylornithine (DFMO) in plasma during pharmacokinetic studies in mice is described, using conventional reversed-phase HPLC with UV detection. It was shown that mice infected with Trypanosoma brucei had Cmax values 2-fold higher than those of non-infected mice. It is concluded that pharmacokinetic studies should compare both infected and naive subjects.

(PDF 0-2 workdays service: $29.90)

Accession: 002811061

Download citation: RISBibTeXText

PMID: 9134564



Related references

Effect of chronic trypanosomiasis on the bioavailability of α-difluoromethylornithine (DFMO) after oral administration: pharmacokinetics study on DFMO plasma levels in infected and noninfected mice using a high-performance liquid chromatography assay. Parasitology Research 83(4): 386-389, 1997

Pharmacokinetics pk of alpha difluoromethylornithine dfmo and levels of polyamines in patients pts receiving dfmo in a phase i chemoprevention study. Proceedings of the American Association for Cancer Research Annual Meeting 31: 182, 1990

Studies on lipidomimetic derivatives of alpha-difluoromethylornithine (DFMO) to enhance the bioavailability in a Trypanosoma B. brucei murine trypanosomiasis model. Parasite 5(3): 239-246, 1998

Functional consequences of polyamine synthesis inhibition by L-alpha-difluoromethylornithine (DFMO): cellular mechanisms for DFMO-mediated ototoxicity. Journal of Biological Chemistry 280(15): 15097-15102, 2005

Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice. Nihon Geka Gakkai Zasshi 90(5): 650-660, 1989

Chemotherapy of CNS-trypanosomiasis: the combined use of diminazene aceturate or pentamidine with DL-alpha-difluoromethylornithine (DFMO). Tropical Medicine and Parasitology 43(2): 106-109, 1992

Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms oftrypanosomabruceibrucei. Veterinary Research Communications 11(3): 271-274, 1987

Towards more efficacious chemotherapy of trypanosomiasis: combination of alpha-difluoromethylornithine (DFMO) with reactive oxygen generating drugs. Medical Hypotheses 36(3): 246-249, 1991

New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin. American Journal of Tropical Medicine and Hygiene 33(6): 1073-1077, 1984

Functional Consequences of Polyamine Synthesis Inhibition by L--Difluoromethylornithine (DFMO): CELLULAR MECHANISMS FOR DFMO-MEDIATED OTOTOXICITY. Journal of biological chemistry15 280(15): 15097-15102, 2005

Effect of alpha difluoromethylornithine dfmo and exogenous putrescine pu administration on the growth and polyamines pa pools of experimental breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 28: 234, 1987

Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei. Veterinary Research Communications 11(3): 271-274, 1987

Phase 1 and pharmacokinetics study of difluoromethylornithine dfmo a potential chemopreventive. Proceedings of the American Association for Cancer Research Annual Meeting 32: 203, 1991

Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO). Radiation Research 108(3): 269-281, 1986

Use of difluoromethylornithine (DFMO, eflornithine) for late-stage African trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 81(4): 701-702, 1987